Introduction
Growth factor independence 1 (Gfi-1) is a nuclear transcriptional repressor that is expressed in hematopoietic stem cells (HSCs), lymphoid and granulocytic cells, as well as in nonhematopoietic tissues, including lung, sensory epithelia, neuronal precursors and the developing epithelia of the inner ear (Moroy, 2005) . In the hematopoietic system, Gfi-1 is required for granulocytic differentiation, and has an important role in T-and B-cell development and in the maintenance of stemcell functional integrity. Gfi-1 À/À mice lack mature neutrophils and have reduced numbers of mature T-and B cells (Karsunky et al., 2002b; Hock et al., 2003; Zhu et al., 2006) . HSCs from Gfi-1 À/À mice show elevated proliferation and are functionally impaired in long-term repopulation and serial transplantation assays (Hock et al., 2004; Zeng et al., 2004) . In nonhematpoietic tissues, Gfi-1 has been shown to regulate the development of inner ear hair cells, lung neuroendocrine cells and intestinal epithelium (Wallis et al., 2003; Kazanjian et al., 2004; Shroyer et al., 2005) .
Increasing evidence indicates that aberrant activation of Gfi-1 may lead to oncogenesis. The Gfi-1 locus was first identified as a provirus integration site that rendered Moloney murine leukemia virus-induced T-cell lymphoma lines independent of interleukin 2 (Gilks et al., 1993) . Overexpression of Gfi-1 was later found to inhibit apoptosis and override cell-cycle arrest induced by growth factor withdrawal (Grimes et al., 1996b; Rodel et al., 2000; Zhu et al., 2002; Karsunky et al., 2002a) . Transgenic mice that overexpress Gfi-1 in T cells are weakly predisposed to lymphoma, and combinatorial activation of Gfi-1 and Myc or Pim-1 leads to accelerated development of lymphoma (Zornig et al., 1996; Scheijen et al., 1997; Schmidt et al., 1998) . These results indicate that Gfi-1 is a weak oncoprotein, but cooperates with Myc and Pim-1 in lymphomagenesis. In addition, Gfi-1 may have a role in the development of lung and prostate cancers (Kazanjian et al., 2004; Dwivedi et al., 2005) .
Gfi-1 consists of a 20 amino acid N-terminal SNAG domain, a middle portion and six C-terminal zinc fingers (ZFs). The transcriptional repression activity of Gfi-1 is dependent on the integrity of its N-terminal SNAG domain (Grimes et al., 1996a) . Gfi-1 represses transcription by directly binding to the consensus DNA sequence AATC through C-terminal ZFs. An asparagine-to-serine substitution in the fifth ZF of Gfi-1 (N382S), identified in patients with severe congenital neutropenia, abolishes the DNA binding activity and the N382S mutant acts in a dominant-negative manner (Person et al., 2003) . Transcriptional repression by Gfi-1 involves recruitment, through its different domains, of corepressors and histone-modifying enzymes, including eight-twenty-one (ETO), CoREST, histone demethylase LSD1, histone deacetylases (HDACs) 1 and 2 and the histone lysine methyltransferase G9a (Grimes et al., 1996a; McGhee et al., 2003; Duan et al., 2005; Saleque et al., 2007) .
Little is known about how Gfi-1 regulates cell-cycle progression and survival. CDKN1A, which encodes the cyclin-dependent kinase inhibitor p21 Cip1 , has been identified as a Gfi-1 target gene. Gfi-1 was shown to bind to the upstream sequences in the CDKN1A promoter and repress transcription by recruiting HDAC1 and G9a (Duan and Horwitz, 2003; Duan et al., 2005) . Indeed, overexpression of Gfi-1 antagonized p21
Cip1 upregulation by phorbol ester in Jurkat T cells (Karsunky et al., 2002a) . Consistent with these observations, the level of p21
Cip1 is increased in mouse Gfi1 À/À T cells (Pargmann et al., 2007) . Interestingly, unlike T cells, deficiency of Gfi-1 in mouse HSCs leads to a reduced expression of p21
Cip1 (Hock et al., 2004; Zeng et al., 2004) . It remains to be determined whether p21
Cip downregulation in Gfi1 À/À HSCs results directly from Gfi-1 deficiency or rather is an indirect event. Irrespectively, these results indicate that the effects of Gfi-1 on p21
Cip1 expression are cell-context dependent. Miz-1 is a POZ domain ZF transcription factor that possesses a potent anti-growth function and was originally identified as a c-Myc interacting protein (Wanzel et al., 2003) . Miz-1 has been implicated in c-Myc-mediated repression of CDKN1A, CDKN2B encoding another cyclin-dependent kinase inhibitor p15 INK4B and Mad4 (Seoane et al., , 2002 Staller et al., 2001; Herold et al., 2002; Kime and Wright, 2003) . Miz-1 binds to the core promoters of these genes and activates their transcription. c-Myc does not directly bind to, but is recruited to them through Miz-1. Transcriptional activation by Miz-1 is abolished on c-Myc recruitment and the Miz-1/c-Myc complex functions to repress transcription. Significantly, the expression of c-Myc is downregulated by the cytostatic cytokine transforming growth factor-b (TGFb), which represents an important mechanism by which TGFb activates CDKN1A and CDKN2B, and exerts its growth-inhibitory effect (Seoane et al., , 2002 . We show here that Gfi-1 is recruited to CDKN1A core promoter through Miz-1 and represses CDKN1A transcription. It is noteworthy that the DNA binding activity of Gfi-1 is dispensable for its repression activity. Our data also indicate that Gfi-1 and c-Myc, through Miz-1, form a ternary complex on the CDKN1A promoter and exhibit functional collaboration in the repression of CDKN1A. Interestingly, similar to c-Myc, Gfi-1 is also downregulated by TGFb and regulates TGFb sensitivity in hematopoietic cells. These results have implications for understanding the action of Gfi-1 in cell proliferation and its collaboration with Myc in lymphomagenesis.
Results
The DNA binding activity of Gfi-1 is not required for repressing TGFb-induced activation of CDKN1A Gfi-1 has been shown to repress CDKN1A, which contains Gfi-1 binding sites B1.4 and 2.8 kb upstream of the transcription initiation site (Duan and Horwitz, 2003; Duan et al., 2005) . We addressed whether direct DNA binding is required for repression of CDKN1A by Gfi-1. Hela cells were transfected with luciferase reporter constructs containing the 2.4 kb or 111 bp fragment of the CDKN1A promoter (Datto et al., 1995) , along with the expression constructs for Gfi-1 and the N382S mutant. Notably, the 111 bp promoter fragment is devoid of a consensus Gfi-1 binding site, and the N382S mutant of Gfi-1 is defective in DNA binding and functions in a dominant-negative manner (Person et al., 2003; Zhuang et al., 2006) . Cells were subsequently stimulated with TGFb, which has been shown to induce the expression of CDKN1A in epithelial cells (Letterio, 2005; Lin et al., 2005) . As shown in Figure 1 , both CDKN1A promoter fragments were activated by TGFb, but were completely inhibited by Gfi-1. The N382S mutant also effectively repressed the two CDKN1A promoter fragments. Together, these data indicate that DNA binding ability is not essential for the inhibitory effect of Gfi-1 on TGFb-induced activation of CDKN1A.
Miz-1 recruits Gfi-1 to the CDKN1A promoter As repression of CDKN1A by Gfi-1 is independent of its DNA binding activity, we speculated that Gfi-1 may be recruited to the CDKN1A promoter by a DNA binding protein. We recently identified Miz-1 as a Gfi-1-interacting protein that recruits Gfi-1 to the CDKN2B promoter and is involved in Gfi-1-mediated repression of CDKN2B (Basu et al., 2009) . Notably, Miz-1 has been shown to recruit c-Myc to the CDKN1A promoter and is required for repression of CDKN1A by c-Myc (Seoane et al., 2002) . Oligonucleotide precipitation assays were conducted to determine whether Gfi-1 bound to the CDKN1A promoter through Miz-1. Miz-1, Gfi-1 or both were transiently transfected into 293T cells. Whole-cell extracts were incubated with the biotinylated double-stranded oligonucleotide spanning À49 bp to þ 16 bp of the CDKN1A promoter, which lacks a consensus Gfi-1 binding site and was used by others to specifically pull down Miz-1 (Seoane et al., 2002; Wu et al., 2003) . Proteins that bound to the oligonucleotide were precipitated using streptavidincoated beads. As expected, Miz-1 was pulled down by the oligonucleotide (Figure 2a) . Notably, Gfi-1 was Miz-1 in repression of CDKN1A by Gfi-1 Q Liu et al pulled down only when Miz-1 was present in the wholecell extracts. The N382S mutant was also recruited to the CDKN1A core promoter by Miz-1 (Figure 2b ), in agreement with its ability to repress CDKN1A. Chromatin immunoprecipitation (ChIP) assays were then conducted on 293T cells ectopically expressing Gfi-1 and Miz-1 to evaluate whether Gfi-1 binding to the CDKN1A promoter in vivo was also dependent on Miz-1. As shown in Figure 2c , Gfi-1 barely bound to the CDKN1A promoter in 293T cells transfected with Gfi-1 only. Expression of Miz-1 in 293T cells markedly increased Gfi-1 occupancy of the CDKN1A core promoter, but not of the upstream and downstream regions. Consistent with this, Miz-1 bound to the proximal promoter region, but not to the upstream and downstream regions of CDKN1A. ChIP assays on HL-60 and Jurkat cells showed that endogenous Gfi-1 also bound to the CDKN1A core promoter in vivo ( Figure 2d ). Interestingly, although the CDKN1A promoter has been shown to contain two Gfi-1 binding sites located B1.4 and 2.8 kb upstream of the transcription initiation sites (Duan and Horwitz, 2003; Duan et al., 2005) , PCR using primers spanning the two sites failed to show significant Gfi-1 binding, suggesting that Gfi-1 may not occupy the two sites in vivo. To further show that Gfi-1 occupancy of the CDKN1A promoter was dependent on Miz-1, the expression of Miz-1 was knocked down in HL-60 cells through lentivirusmediated delivery of the Miz-1 short hairpin RNA (shRNA). As shown in Figure 2e , Miz-1 knockdown significantly reduced Gfi-1 occupancy of the CDKN1A promoter. Together, these data indicate that Gfi-1 bound to the CDKN1A core promoter through Miz-1.
The C-terminal ZFs of Gfi-1 are involved in interaction with Miz-1 To define the Gfi-1 region implicated in Miz-1 interaction, a series of Gfi-1 mutants ( Figure 3a ) were generated and expressed in 293T cells, along with Myc-tagged Miz-1. Coimmunoprecipitation assays showed that truncation of the N-terminal SNAG domain
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Miz-1 recruits Gfi-1 to the core promoter of CDKN1A. (a, b) 293T cells were transfected with Gfi-1 or the N382S mutant, either alone or together with Miz-1. Whole-cell extracts were subjected to precipitation using the CDKN1A promoter oligonucleotide and examined for the indicated proteins by western blot analysis. (c) 293T cells were transfected with Gfi-1 and/or Miz-1. Chromatin DNA from cells was immunoprecipitated using antibodies against Gfi-1, Miz-1 or an irrelevant species-matched antibody (control). The indicated regions of CDKN1A promoter were amplified by semiquantitative PCR. (d) ChIP assays were performed on HL-60 and Jurkat cells. The indicated promoter regions of CDKN1A were amplified by semiquantitative PCR. (e) HL-60 cells were infected with the empty (Ctr) or Miz-1 shRNA lentiviral construct. ChIP assays were performed using the anti-Gfi-1 antibody, followed by PCR amplification of the CDKN1A core promoter region. Expression of Miz-1 was examined by western blot analysis.
Miz-1 in repression of CDKN1A by Gfi-1 Q Liu et al (Gfi-1-dN) had no noticeable effect on the ability of Gfi-1 to interact with Miz-1 (Figure 3b ). However, deletion of the C-terminal 3 (Gfi-1-dZF3) or 6 (Gfi-1dZF6) ZFs of Gfi-1 abolished Miz-1 interaction, indicating that the C-terminal ZFs 4-6 are required for Miz-1 interaction. Accordingly, Gfi-1-dN, but not Gfi-1-dZF6, was recruited to the CDKN1A promoter by Miz-1 (Figure 3c ).
Gfi-1 represses the activation of CDKN1A by Miz-1 As Gfi-1 was recruited to CDKN1A through Miz-1, we examined the role of Gfi-1 in Miz-1-mediated activation of the CDKN1A promoter using luciferase reporter assay. As shown in Figure 4a , the 2.4 kb promoter fragment of CDKN1A was activated by Miz-1 in Hela cells, but was repressed by Gfi-1 in a dose-dependent manner. Notably, Gfi-1 also repressed Miz-1-mediated activation of the 111 bp core promoter fragment of CDKN1A (Figure 4b ). The activity of the 111 bp promoter fragment was also inhibited by the N382S mutant ( Figure 4c ). Thus, analogous to its effect on TGFb-induced activation of CDKN1A, repression of Miz-1-activated CDKN1A by Gfi-1 is also independent of direct DNA binding.
To provide evidence that Gfi-1 repressed endogenous CDKN1A, we assessed the effect of Gfi-1 knockdown on the level of p21
Cip1 in myeloid leukemic HL-60 and TF-1 cells, as well as in pro-B Ba/F3 cells. Lentiviral delivery of Gfi-1 shRNAs, but not of the empty vector, significantly reduced the expression of Gfi-1, which was associated with increased levels of p21
Cip in the cells Figure 4d ). We also examined the effect of Gfi-1 knockdown on cell proliferation. Compared with cells infected with the empty lentiviral vector or shRNAs that failed to knockdown Gfi-1, cells in which Gfi-1 was knocked down initially grew extremely slowly. The growth-inhibitory effect of Gfi-1 knockdown became less apparent after prolonged culture. Sufficient amounts of cells could be collected for evaluation of Gfi-1 expression and cell proliferation B6 weeks after lentiviral delivery of the Gfi-1 shRNA. At that time, Gfi-1 knockdown exhibited moderate inhibitory effects on cell proliferation ( Figure 5 ).
Miz-1 in repression of
Gfi-1 and c-Myc collaboratively repress CDKN1A Because Gfi-1 and c-Myc both interact with Miz-1 and repress transcription activated by Miz-1, we addressed the possibility that Gfi-1 may functionally collaborate with c-Myc in repressing CDKN1A. Luciferase reporter assays using the 2.4 kb fragment of the CDKN1A promoter were performed in Hela cells transiently transfected with Gfi-1 and c-Myc. As expected, expression of either Gfi-1 or c-Myc inhibited Miz-1-stimulated activity of the CDKN1A promoter (Figure 6a) . Notably, coexpression of Gfi-1 and c-Myc resulted in further inhibition of the CDKN1A promoter activity. We performed oligonucleotide precipitation assays to determine whether Gfi-1 and c-Myc were both recruited to the CDKN1A core promoter through Miz-1 in 293T cells transfected with Gfi-1 and c-Myc with or without Miz-1. As shown in Figure 6b , Gfi-1 and c-Myc were pulled down by the CDKN1A promoter oligonucleotide in the presence of Miz-1, but not in its absence. Re-ChIP assays were performed to further evaluate whether Gfi-1, Miz-1 and c-Myc occupied the CDKN1A promoter as a ternary complex in 293T cells. Soluble chromatin from cells was immunoprecipitated with anti-Gfi-1 antibody, eluted from beads and reimmunoprecipitated with the anti-c-Myc antibody before analysis of the sequences surrounding the CDKN1A promoter by semiquantitative PCR. The CDKN1A core promoter sequence, but not the upstream and downstream regions, was immunoprecipitated with anti-Gfi-1 and anti-c-Myc antibodies only if Miz-1 was expressed in cells (Figure 6c ). The CDKN1A core promoter sequence was not detected when the irrelevant species-matched antibody was used for immunoprecipitation in the Re-ChIP experiments (Figure 6d) . Together, the results showed that Gfi-1, Miz-1 and c-Myc bind to the CDKN1A core promoter as a ternary complex. Miz-1 in repression of CDKN1A by Gfi-1 Q Liu et al
TGFb treatment inhibits the expression of Gfi-1 in hematopoietic cells
It has been shown that TGFb upregulates p21 Cip1 at least in part by inhibiting the expression of c-Myc, and enforced expression of c-Myc confers cells with resistance to the cytostatic effect of TGFb (Kim and Letterio, 2003; Letterio, 2005; Lin et al., 2005) . To investigate the effect of TGFb treatment on the expression of Gfi-1, HL-60, TF-1 and U937 cells were incubated with TGFb for different time periods and examined for Gfi-1 expression by semiquantitative PCR and western blot analyses. TGFb treatment dramatically reduced the levels of Gfi-1 mRNA and protein (Figure 7) . Essentially identical results were obtained in another myeloid cell line Mo7e (data not shown). Thus, similar to c-Myc, the expression of Gfi-1 is also downregulated by TGFb treatment.
Gfi-1 attenuates the cytostatic effect of TGFb
Transforming growth factor-b has been shown to exert a cytostatic effect on early hematopoietic progenitors and stem cells, whereas leukemia-derived cells are resistant to this effect (Letterio, 2005; Lin et al., 2005) . We addressed whether the expression level of Gfi-1 affected cellular response to TGFb. Murine Pro-B Ba/F3 cells, which were sensitive to the cytostatic effect of TGFb (Luo and Lodish 1996) , were transiently transfected with the retroviral expression construct Gfi-1-RV and sorted on the basis of GFP expression. Transfection of Ba/F3 cells with Gfi-1 moderately counteracted the cytostatic effect of TGFb (Figure 8a ). We further examined the effect of Gfi-1 knockdown on the TGFb response of Ba/F3 cells. Consistent with the results obtained in HL-60 and TF-1 cells, Gfi-1 knockdown through lentivirus-mediated delivery of Gfi-1 shRNA inhibited the proliferation of Ba/F3 cells (Figure 8b) . Significantly, the Gfi-1 knocked-down Ba/F3 cells exhibited markedly increased sensitivity to the cytostatic effect of TGFb. These data implicate Gfi-1 as an important regulator of cell sensitivity to TGFb.
Discussion
In this paper, we have shown that Gfi-1 interacts with Miz-1 through its C-terminal ZF domains and, through Miz-1, is recruited to the CDKN1A promoter, resulting in transcriptional repression. Consistent with this, repression of CDKN1A by Gfi-1 is independent of its DNA binding activity, as evident from the facts that Gfi-1 represses the 111 bp CDKN1A promoter fragment, which is devoid of a Gfi-1 binding site, and the DNA-binding defective N382S mutant of Gfi-1 is fully capable of repressing CDKN1A promoter activity. We recently showed that Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1 (Basu et al., 2009) . The data presented here add CDKN1A to the list of genes that are regulated by Gfi-1 through Miz-1. CDKN1A has been shown to contain two Gfi-1 binding sites located at approximately À1.4 and À2.8 kb in the CDKN1A promoter (Duan and Horwitz, 2003; Duan et al., 2005) . Gfi-1 occupancy of the CDKN1A promoter was confirmed in HL-60 cells by ChIP assays in which the CDKN1A promoter fragment spanning from approximately À390 to À250 bp was amplified by PCR (Duan and Horwitz, 2003) . However, we were unable to show significant Gfi-1 binding using PCR primers that flank the two sites in our ChIP assays, although Gfi-1 binding to the CDKN1A core promoter was consistently detected in HL60 and Jurkat cells, suggesting that Gfi-1 may not bind to the upstream regions of the CDKN1A promoter in vivo. Notably, Miz-1 knockdown significantly reduced Gfi-1 binding in vivo to the CDKN1A promoter. These data suggest that Miz-1 may be required for Gfi-1 binding to the CDKN1A promoter.
Miz-1 has been implicated in c-Myc-mediated repression of CDKN1A, CDKN2B and Mad4 (Seoane et al., , 2002 Staller et al., 2001; Herold et al., 2002; Kime and Wright, 2003) . Similar to Gfi-1, c-Myc does not bind to, but is recruited to, the CDKN1A core promoter through Miz-1. Notably, the C-terminal ZFs 1-12 of Miz-1 are involved in interaction with Gfi-1, whereas the regions flanking ZFs 1-12 are required for binding to Myc (Peukert et al., 1997; Basu et al., 2009) . Thus, Miz-1 may interact simultaneously with Gfi-1 and Myc through distinct regions. Our data indicate that Gfi-1 and c-Myc form a ternary complex with Miz-1 on the CDKN1A promoter and exhibit functional cooperation in repressing CDKN1A. We have recently shown that Gfi-1 cooperates with c-Myc in repressing CDKN2B (Basu et al., 2009) . Taken together, these results support a model in which Miz-1 recruits Gfi-1 and c-Myc to form the Gfi-1/Miz-1/c-Myc ternary complex on the core promoters of CDKN1A, CDKN2B and probably other Miz-1 target genes, leading to cooperative repression of these genes by Gfi-1 and c-Myc. Interestingly, Gfi-1 has been shown to collaborate with c-Myc in lymphomagenesis (Zornig et al., 1996; Scheijen et al., 1997; Schmidt et al., 1998) . Our data, although not directly addressing, offer a potential explanation for the role of Gfi-1 in Myc-induced lymphomagenesis (Zornig et al., 1996; Scheijen et al., 1997; Schmidt et al., 1998) .
Transforming growth factor-b inhibits the proliferation of epithelial and early hematopoietic cells, and impaired TGFb signaling has been implicated in hematopoietic and epithelial malignancies (Letterio, 2005; Lin et al., 2005) . The cytostatic effect of TGFb is dependent on its ability to induce the expression of p21
Cip1 and p15 INK4B at least in part through rapid downregulation of c-Myc (Chen et al., 2002; Yagi et al., 2002; Frederick et al., 2004) . Our data indicate that Gfi-1 also suppresses TGFb-induced activation of CDKN1A and counteracts the cytostatic effect of TGFb. Significantly, similar to c-Myc, the expression of Gfi-1 is downregulated by TGFb at both mRNA and protein levels, consistent with a recent study ). Thus, TGFb downregulates both Gfi-1 and c-Myc, which may release Miz-1 from the Gfi-1/Miz-1/c-Myc complex to activate CDKN1A, CDKN2B and other possible target genes involved in the negative regulation of cell proliferation (Figure 9 ). It is possible that suppression of TGFb-induced activation of CDKN1A and other Miz-1 target genes may contribute to the oncogenic potential of Gfi-1.
Although Gfi-1 has been implicated in the pathogenesis of lymphomas, little is known about its role in leukemogenesis. It has been shown recently that Gfi-1 may suppress leukemogenesis through repression of HoxA9, Pbx1 and Meis1, which are required for immortalization and expansion of hematopoietic stem and progenitor cells (Horman et al., 2009) . However, our results indicate that shRNA-mediated knockdown of Gfi-1 in myeloid leukemic cells led to Miz-1 in repression of CDKN1A by Gfi-1 Q Liu et al attenuated cell proliferation. The growth-inhibitory effect of Gfi-1 knockdown seemed to be dramatic at early stages of Gfi-1 knockdown, but became less significant on prolonged culture, suggesting that leukemic cells may develop compensatory mechanisms. Further studies are needed to investigate the role of Gfi-1 in leukemogenesis.
Materials and methods

Cells
HeLa and 293T cells were maintained in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin solution. The human myeloid leukemic cell lines HL-60, TF-1 and U937, as well as the leukemic T-cell line Jurkat, were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and antibiotics. Murine Pro-B Ba/F3 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum and 10% WEHI-3B cell-conditioned media as a crude source of murine interleukin-3. The cells were grown in a humidified incubator at 37 1C with 5% CO2.
Reagents
Human TGFb-1 was purchased from PeproTech (Rocky Hill, NJ, USA). Antibodies against Gfi-1 (N-20), Miz-1 (N17), the ExactaCruz D kit used in coimmunoprecipitation experiments and protein A/G beads were purchased from Santa Cruz Biotechnolgy (Santa Cruz, CA, USA). Monoclonal anti-Miz-1 antibody 10E2 was kindly provided by Dr M Eilers (University of Marburg, Germany) and used in western blot analysis. Anti-b-actin antibody was from Sigma (St Louis, MO, USA). The pLKO.1 lentiviral constructs containing shRNAs against Gfi-1 and Miz-1 were purchased from Open Biosystems (Huntsville, AL, USA). Lipofectamine 2000 and TransIT-LT1 transfection reagent were purchased from Invitrogen (Carlsbad, CA, USA) and Mirus (Madison, WI, USA), respectively. Luciferase assay reagents were from Promega (Madison, WI, USA).
Construction of vectors
The pcDNA3.1/Myc-His expression constructs for Miz-1 and Myc-tagged Miz-1, and the retroviral expression constructs for Gfi-1 (Gfi-1-RV) and the N382S mutant (N382S-RV) containing internal ribosomal entry sequences and humanized GFP cDNA, have been described (Zhuang et al., 2006; Basu et al., 2009) . Rat Gfi-1 cDNA was kindly provided by Dr PN Tsichlis (Fox Chase Cancer Center, Philadelphia, PA, USA) and cloned into the pcDNA3.1/Myc-His plasmid. The Myc tag sequence of the pcDNA3.1/Myc-His plasmid was subsequently replaced with the sequence encoding the Flag tag. Gfi-1 dN, dZF3 and dZF6 mutants were generated using the PCR-based strategy. The CDKN1A luciferase reporter constructs containing 2.4 kb and 111 bp fragments of human CDKN1A promoter (Datto et al., 1995) were kindly provided by Dr XF Wang (Duke University, Durham, NC, USA).
Immunoprecipitation and western blot analysis Cells (that is, 293T cells) transiently transfected with Myctagged Miz-1 and Flag-tagged Gfi-1 or mutants were lysed in lysis buffer (1% Triton X-100, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 20 mM NaF and 1 mM phenylmethylsulfonyl fluoride). Whole-cell extracts were subjected to immunoprecipitation using the anti-Flag antibody. Immunocomplexes were recovered with protein A/G beads and washed five times with lysis buffer. Samples were boiled in SDS sample buffer and resolved by SDS-polyacrylamide gel electrophoresis before transfer to Immobilon membranes (Millipore Corporation, Billerica, MA, USA). The membranes were incubated with the appropriate antibodies and the reactive proteins were visualized by enhanced chemiluminescence.
Oligonucleotide precipitation analysis Cells (that is, 293T cells) were transfected with Gfi-1, Miz-1 or their mutants, and lysed 48 h after transfection in HKMG buffer (10 mM Hepes (pH 7.9), 100 mM KCl, 5 mM MgCl 2 , 10% glycerol, 1 mM dithiothreitol and 1% NP40). Whole-cell lysates were incubated overnight at 4 1C with the biotinylated doublestranded oligonucleotide spanning from À49 bp to þ 16 bp of the CDKN1A promoter in the presence of 25-fold excess of poly(dI-dC). Bound proteins were collected with streptavidinagarose beads. The beads were washed three times in HKMG buffer before western blot analysis.
ChIP and Re-ChIP Cells were fixed with 1% formaldehyde for 10 min at 37 1C and lysed in hypotonic buffer (5 mM Tris-HCl (pH 7.5), 85 mM KCl and 0.5% NP40). After centrifugation at 6000 r.p.m. for 5 min, nuclei were lysed in ChIP lysis buffer (1% SDS, 10 mM EDTA and 50 mM Tris-HCl (pH 7.5)) and sonicated to shear chromatin DNA to about 500 bp fragments. Nuclear lysates were diluted eight times with ChIP dilution buffer (1.1% Triton X-100, 0.01% SDS, 1.2 mM EDTA, 16.7 mM Tri-HCl (pH 8) and 167 mM NaCl), precleared with protein A/Gagarose beads and rabbit normal IgG for 1 h and subjected to immunoprecipitation with anti-Miz-1, anti-Gfi-1 or a speciesmatched irrelevant antibody. Precipitated chromatin DNA was amplified by PCR using primers spanning the different regions of the CDKN1A promoter. For Re-ChIP assays, DNA-protein complexes immunoprecipitated with the antiGfi-1 antibody in primary ChIP were eluted with 25 ml of 10 mM dithiothreitol for 30 min at 37 1C and diluted 20 times with Re-ChIP buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris-HCl (pH 7.5)). The complexes were then subjected to reimmunoprecipitation with the anti-c-Myc antibody before analysis of the precipitated chromatin DNA by semiquantitative PCR.
RNA interference
Cells (that is, 293T cells) were transfected with shRNA lentiviral constructs, along with packaging plasmids, using lipofectamine 2000. Supernatants containing viruses were harvested 48 and 72 h after transfection. HL-60, TF-1 and Ba/F3 cells were infected with viral supernatants in the presence of 8 mg/ml of polybrene and selected with 2 mg/ml puromycin 48 h later. Cells that survived puromycin selection were examined for expression of Gfi-1 and Miz-1 by western blot analysis. Alternatively, lentivirus-infected cells were subcloned by limiting dilution and individual clones were examined for Gfi-1 expression.
Luciferase reporter assay HeLa cells were transfected using lipofectamine 2000. At 48 h after transfection, cells were harvested with or without pretreatment with TGFb (5 ng/ml) for 6 h. Luciferase activities were measured using a Molecular Devices Lmax luminometer (Sunnyvale, CA, USA) and normalized on the basis of cotransfected b-galactosidase activity.
